GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » Debt-to-EBITDA

Asymchem Laboratories Tianjin Co (SZSE:002821) Debt-to-EBITDA : 0.17 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Asymchem Laboratories Tianjin Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥32 Mil. Asymchem Laboratories Tianjin Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥132 Mil. Asymchem Laboratories Tianjin Co's annualized EBITDA for the quarter that ended in Jun. 2024 was ¥960 Mil. Asymchem Laboratories Tianjin Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 was 0.17.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Asymchem Laboratories Tianjin Co's Debt-to-EBITDA or its related term are showing as below:

SZSE:002821' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.03   Med: 0.31   Max: 0.47
Current: 0.14

During the past 13 years, the highest Debt-to-EBITDA Ratio of Asymchem Laboratories Tianjin Co was 0.47. The lowest was 0.03. And the median was 0.31.

SZSE:002821's Debt-to-EBITDA is ranked better than
83.39% of 271 companies
in the Biotechnology industry
Industry Median: 1.38 vs SZSE:002821: 0.14

Asymchem Laboratories Tianjin Co Debt-to-EBITDA Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Debt-to-EBITDA Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.04 0.31 0.03 0.05

Asymchem Laboratories Tianjin Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.06 0.50 0.12 0.17

Competitive Comparison of Asymchem Laboratories Tianjin Co's Debt-to-EBITDA

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's Debt-to-EBITDA falls into.



Asymchem Laboratories Tianjin Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Asymchem Laboratories Tianjin Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(40.763 + 106.486) / 3026.984
=0.05

Asymchem Laboratories Tianjin Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(32.416 + 132.476) / 959.776
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2024) EBITDA data.


Asymchem Laboratories Tianjin Co  (SZSE:002821) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Asymchem Laboratories Tianjin Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Asymchem Laboratories Tianjin Co Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.
Executives
Xiao Yi Executives
Xu Xiang Ke Directors, executives
Zhou Yan Executives
Chen Chao Yong Executives
Huang Xiao Lian Executives
Yang Jing Director
Executives

Asymchem Laboratories Tianjin Co Headlines

No Headlines